11/24/2025
November is National Diabetes Awareness Month and at Basil Clinical, we’re committed to expanding access, education, and early detection across the full spectrum of metabolic health.
Diabetes affects millions across the U.S., but it rarely exists in isolation. Conditions like fatty liver disease, obesity, insulin resistance, and other cardiometabolic disorders often develop silently for years before symptoms appear.
Early detection is everything and it starts with knowing your numbers.
At Basil Clinical, our metabolic team provides comprehensive research-driven evaluation to help individuals understand their risk and access emerging treatments.
Our assessments include:
🔬 A1C and glucose screening
🧪 Advanced metabolic and lipid testing
🫁 Non-invasive FibroScan® for fatty liver disease (NAFLD/NASH)
❤️ Cardiometabolic measurements such as BMI, waist circumference, blood pressure, and inflammatory markers
📊 Personalized eligibility assessments for cutting-edge clinical trials
Through our clinical trials and IRB-approved pre-study programs, we are helping participants:
✔️ Understand their metabolic risk profile
✔️ Access investigational treatments not yet available outside research
✔️ Receive individualized support from our clinical and medical team
✔️ Contribute to advancing the future of diabetes and metabolic care
This month, take time to check in with your health. Encourage loved ones to get screened. Awareness and early testing save lives.
If you or someone you know may benefit from metabolic screening or participation in a diabetes-related clinical trial, Basil Clinical is here to help guide the way.
